Tech Company Financing Transactions
Neurotech Pharmaceuticals Funding Round
Private investors participated in a $15 million Series B capital raise for Neurotech Pharmaceuticals. The round was announced by the company on 10/22/2008.
Transaction Overview
Company Name
Announced On
10/22/2008
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900 Highland Corporate Dr. Building 1 101
Lincoln, RI 02864
USA
Lincoln, RI 02864
USA
Phone
Website
Email Address
Overview
Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new medical therapies are the largest market opportunity in ophthalmology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Small
VP - Bus. Development
Konrad Kauper
Browse more venture capital transactions:
Prev: 10/21/2008: Trusteer venture capital transaction
Next: 10/22/2008: AdMob venture capital transaction
Share this article
News on VC Transactions
We document tech company VC transactions. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs